Mochida Pharmaceutical announced that it had entered into a US distribution partnership with PBC Biomed for ReFeel, a nerve regeneration guidance material. Mochida Medical USA will work with PBC Biomed to expand distribution nationwide.
Mochida Pharmaceutical announced at 11:00 on 9 October that it had entered into a US distribution partnership agreement with PBC Biomed for ReFeel, a nerve regeneration guidance material. Sales in the US will be pursued by the company's US subsidiary, Mochilda Medical USA, in cooperation with PBC Biomed.
ReFeel is a medical device consisting of sodium alginate and polyglycolic acid nonwoven fabric. It is intended to promote repair and regeneration by maintaining an environment conducive to nerve regeneration at sites of nerve injury. The company aims to grow its biomaterials business through expansion in the US market.